March 10, 2015

The Food and Drug Administration recently published bio-equivalence guidance documents. 

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 5, 2015

Rite Aid sees increase in year-to-date comps as total sales increase 3.7%.

March 4, 2015

In preparation for the Consumer Healthcare Products Association’s 2015 Annual Executive Conference being held in Bonita Springs, Fla., this month, Drug Store News sat down with both Scott Melville, CHPA president and CEO, and Patrick Lockwood-Taylor, CHPA chair and VP personal health care, North America, for Procter & Gamble.

March 4, 2015

Miraculins in January announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario beginning in February.

March 4, 2015

The introduction in January of bipartisan legislation that would grant retail pharmacists provider status for Medicare patients in “underserved” communities certainly sounds like a step in the right direction.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change. 

February 24, 2015

NPA  renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.

February 24, 2015

Researchers found that switching glaucoma patients to a generic prostaglandin analogue improved adherence. 

 

February 23, 2015

Combined Distributors reported that its medicine disposal product was found to exceed U.S. FDA and EPA guidelines. 

February 23, 2015

Surescripts expands reach of its electronic prior authorization solution and now reaches 250,000 prescribers.

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 20, 2015

Walgreens to celebrate fifteenth flagship location in Honolulu.

 

February 19, 2015

Walgreens on Thursday announced that Ibrance (palbociclib) is immediately available through Walgreens Specialty Pharmacy.

February 19, 2015

IRI and Kline & Co. establish an exclusive alliance to provide clients with a greater level of actionable insights.

February 19, 2015

Surescripts on Thursday released a step-by-step video guide targeting both small providers and health systems to enable adoption of electronic prescribing of controlled substances.

February 18, 2015

Actavis on Wednesday announced that it will adopt a new corporate name — Allergan — following the anticipated, successful completion of the acquisition of Allergan.

February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.

February 17, 2015

Teva Pharmaceuticals on Tuesday announced the launch of generic versions of Lovenox (enoxaparin sodium injection) as well as generic Zyvox (linezolid) injection. 

 

February 13, 2015

In response to the New York Attorney General’s recent recall of herbal supplements from four major retailers, the Council for Responsible Nutrition has assembled a microsite for consumers.